AMLX
Price
$8.41
Change
+$0.73 (+9.51%)
Updated
Jul 14 closing price
Capitalization
749.68M
23 days until earnings call
ATRA
Price
$9.32
Change
+$0.02 (+0.22%)
Updated
Jul 15, 12:34 PM (EDT)
Capitalization
55.44M
Interact to see
Advertisement

AMLX vs ATRA

Header iconAMLX vs ATRA Comparison
Open Charts AMLX vs ATRABanner chart's image
Amylyx Pharmaceuticals
Price$8.41
Change+$0.73 (+9.51%)
Volume$2.34M
Capitalization749.68M
Atara Biotherapeutics
Price$9.32
Change+$0.02 (+0.22%)
Volume$112
Capitalization55.44M
AMLX vs ATRA Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. ATRA commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a StrongBuy and ATRA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 15, 2025
Stock price -- (AMLX: $8.41 vs. ATRA: $9.30)
Brand notoriety: AMLX and ATRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 159% vs. ATRA: 56%
Market capitalization -- AMLX: $749.68M vs. ATRA: $55.44M
AMLX [@Biotechnology] is valued at $749.68M. ATRA’s [@Biotechnology] market capitalization is $55.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileATRA’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • ATRA’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while ATRA’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • ATRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMLX and ATRA are a good buy in the short-term.

Price Growth

AMLX (@Biotechnology) experienced а +24.41% price change this week, while ATRA (@Biotechnology) price change was +8.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.48%. For the same industry, the average monthly price growth was +21.25%, and the average quarterly price growth was +31.32%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

ATRA is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+10.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($750M) has a higher market cap than ATRA($55.4M). AMLX YTD gains are higher at: 122.487 vs. ATRA (-30.128). ATRA has higher annual earnings (EBITDA): -5.74M vs. AMLX (-206.81M). AMLX has more cash in the bank: 204M vs. ATRA (13.8M). AMLX has less debt than ATRA: AMLX (1.38M) vs ATRA (40.6M). ATRA has higher revenues than AMLX: ATRA (200M) vs AMLX (-1.27M).
AMLXATRAAMLX / ATRA
Capitalization750M55.4M1,354%
EBITDA-206.81M-5.74M3,601%
Gain YTD122.487-30.128-407%
P/E Ratio2.69N/A-
Revenue-1.27M200M-1%
Total Cash204M13.8M1,478%
Total Debt1.38M40.6M3%
FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXATRA
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 23 days ago
82%
Bearish Trend 23 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OEPIX67.27N/A
N/A
Oil Equipment&Svcs UltraSector Pro Inv
GEGTX80.77N/A
N/A
Columbia Large Cap Growth Inst
GCVCX23.98N/A
N/A
Goldman Sachs Large Cp Val Insghts C
MGFAX9.74N/A
N/A
MassMutual Global A
FIQJX23.45N/A
N/A
Fidelity Advisor Intl Sm Cap Opps Z

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+9.51%
XOMAO - AMLX
68%
Closely correlated
+0.03%
XOMAP - AMLX
51%
Loosely correlated
+0.19%
OCUL - AMLX
45%
Loosely correlated
+2.18%
RGNX - AMLX
45%
Loosely correlated
+0.23%
PRME - AMLX
43%
Loosely correlated
+10.46%
More